The HLA class II allele DRB1*15:01 exerts the single strongest effect (1, 2), but several alleles within the HLA region have been shown to influence MS risk independently of DRB1*15:01 status, including A*02:01 which is negatively associated with MS (2, 3). This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.